Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Mclean, Virginia
- Most recent report
- 8-K, filed Oct 23, 2026
- Incorporated
- Delaware
- Filings on record
- 45 filings
- On EDGAR
- CIK 2002988
- Fiscal year ends
- December
- Filer status
- Emerging growth company
News 2
Prospectuses and Registrations 5
Ownership 8 of 27
- 4 Insider reported a trade Nov 4, 2026
- 3 Insider reported their initial holding Nov 4, 2026
- 4 Insider reported a trade Oct 22, 2026
- 3 Insider reported their initial holding Oct 16, 2026
- SCHEDULE 13G Large holder reported a passive stake Oct 16, 2026
- SCHEDULE 13G Large holder reported a passive stake Oct 16, 2026
- SCHEDULE 13G Large holder reported a passive stake Oct 15, 2026
- SCHEDULE 13D Large holder reported an active stake Oct 14, 2026
Other 8 of 11
- EFFECT Notice that a registration became effective Oct 8, 2026
- S-1MEF Oct 8, 2026
- CERT Exchange certified a listing Oct 8, 2026
- 8-A12B Registration of a security for exchange listing Oct 8, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Aug 14, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Jun 16, 2026
- DRS/A Draft registration statement, submitted confidentially, amended May 1, 2026
- DRS Draft registration statement, submitted confidentially Feb 17, 2026
Everything here comes from Retension Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.